Xu Fengguo, Liu Ying, Dong Haijuan, Song Rui, Zhang Zunjian
Key Laboratory ofDrug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, Nanjing, 210009, China.
Nat Prod Commun. 2010 May;5(5):795-800.
Da-Cheng-Qi decoction (DCQD) is a purgative compound prescription used in China and East Asia. In this paper, pharmacokinetic differences of six major active components (rhein, emodin, aloe-emodin, magnolol, naringenin and hesperetin) between DCQD and its three constitutional herbal medicines, i.e., Radix et Rhizoma Rhei, Cortex Magnoliae officinalis and Fructus Aurantii Immaturus were investigated in rats after oral administration. Plasma samples were analyzed for the quantification of the six active components using validated LC-MS/MS methods. Unpaired Student's t-test was used for statistical comparison. Significant differences (p < 0.05) in the main pharmacokinetic parameters for rhein, emodin, aloeemodin, magnolol, naringenin and hesperetin were found between DCQD and the decoction of its constitutional single herbal medicines, which demonstrated the presence of drug-drug interactions between these constitutional raw materials of DCQD occurring either in the procedure of decoction or during ADME process.
大承气汤(DCQD)是一种在中国和东亚使用的泻下复方制剂。本文研究了大鼠口服给药后,DCQD与其三味组成草药(即大黄、厚朴和枳实)之间六种主要活性成分(大黄酸、大黄素、芦荟大黄素、厚朴酚、柚皮苷和橙皮苷)的药代动力学差异。采用经过验证的液相色谱-串联质谱法(LC-MS/MS)分析血浆样本,以定量六种活性成分。使用非配对学生t检验进行统计学比较。结果发现,DCQD与其组成单味草药的煎剂之间,大黄酸、大黄素、芦荟大黄素、厚朴酚、柚皮苷和橙皮苷的主要药代动力学参数存在显著差异(p < 0.05),这表明DCQD的这些组成原料药在煎煮过程或吸收、分布、代谢和排泄(ADME)过程中存在药物-药物相互作用。